Central America North America South America Middle East Eastern Europe Asia Western Europe Australia Africa
All India
Product Description
Eculizumab is a medication used to treat certain blood disorders, including paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It works by blocking a protein in the blood called complement, which can attack and destroy red blood cells and cause organ damage.
The typical recommended dose of Eculizumab injection depends on the individual patient's medical condition and body weight. The medication is administered by a healthcare professional in a clinical setting and may require regular monitoring.
The injection is given intravenously (into a vein) over a period of time, usually once a week or every other week, depending on the patient's medical condition and response to the medication.
Common side effects of Eculizumab may include headache, nausea, fatigue, and fever. More serious side effects may include increased risk of infection, allergic reactions, and blood clots. If you experience any concerning symptoms or side effects, be sure to speak with your doctor as soon as possible.